Search
22/08/2022
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Caravaca-Fontan, F, Rivero, M, Cavero, T, Diaz-Encarnacion, M, Cabello, V, Ariceta, G, Quintana, LF, Marco, H, Barros, X, Ramos, N, Rodriguez-Mendiola, N, Cruz, S, Fernandez-Juarez, G, Rodriguez, A, de Jose, AP, Rabasco, C, Rodado, R, Fernandez, L, Perez-Gomez, V, Avila, A, Bravo, L, Espinosa, N, Allende, N, de la Nieta, MDS, Rodriguez, E, Olea, T, Melgosa, M, Huerta, A, Miquel, R, Mon, C, Fraga, G, de Lorenzo, A, Draibe, J, Gonzalez, F, Shabaka, A, Lopez-Rubio, ME, Fenollosa, MA, Martin-Penagos, L, Da Silva, I, Titos, JA, de Cordoba, SR, de Jorge, EG, Praga, M. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy. Clinical Kidney Journal. 2022; 15(9)DOI:10.1093/ckj/sfac108. PMID:36003665. IF:4.600(Q1/2D).
01/08/2022
Deep Molecular Characterization of Milder Spinal Muscular Atrophy Patients Carrying the c.859G > C Variant in SMN2
Blasco-Perez, L, Costa-Roger, M, Leno-Colorado, J, Bernal, S, Alias, L, Codina-Sola, M, Martinez-Cruz, D, Castiglioni, C, Bertini, E, Travaglini, L, Millan, JM, Aller, E, Sotoca, J, Juntas, R, Hoei-Hansen, CE, Moreno-Escribano, A, Guillen-Navarro, E, Costa-Comellas, L, Munell, F, Boronat, S, Rojas-Garcia, R, Povedano, M, Cusco, I, Tizzano, EF. Deep Molecular Characterization of Milder Spinal Muscular Atrophy Patients Carrying the c.859G > C Variant in SMN2. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(15)DOI:10.3390/ijms23158289. PMID:35955418. IF:5.600(Q1/3D).
01/07/2022
Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020
Ars, E, Bernis, C, Fraga, G, Furlano, M, Martinez, V, Martins, J, Ortiz, A, Perez-Gomez, MV, Rodriguez-Perez, JC, Sans, L, Torra, R. Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020. NEFROLOGIA. 2022; 42(4)DOI:10.1016/j.nefro.2021.05.009. PMID:36404270. IF:2.600(Q3/6D).
23/06/2022
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Caravaca-Fontan, F, Diaz-Encarnacion, M, Cabello, V, Ariceta, G, Quintana, LF, Marco, H, Barros, X, Ramos, N, Rodriguez-Mendiola, N, Cruz, S, Fernandez-Juarez, G, Rodriguez, A, de Jose, AP, Rabasco, C, Rodado, R, Fernandez, L, Gomez, VP, Avila, A, Bravo, L, Espinosa, N, Allende, N, de la Nieta, MDS, Rodriguez, E, Olea, T, Melgosa, M, Huerta, A, Miquel, R, Mon, C, Fraga, G, de Lorenzo, A, Draibe, J, Cano-Megias, M, Gonzalez, F, Shabaka, A, Lopez-Rubio, ME, Fenollosa, MA, Martin-Penagos, L, Da Silva, I, Titos, JA, de Cordoba, SR, de Jorge, EG, Praga, M. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(7)DOI:10.1093/ndt/gfab075. PMID:33779754. IF:6.100(Q1/2D).